GOLDMAN SACHS GROUP INC - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 163 filers reported holding ROCKET PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$10,853,940
-62.1%
529,719
-63.2%
0.00%
-66.7%
Q2 2023$28,630,873
+1.2%
1,440,910
-12.8%
0.01%0.0%
Q1 2023$28,294,076
+40.5%
1,651,727
+60.5%
0.01%
+20.0%
Q4 2022$20,140,737
-38.0%
1,029,164
-49.5%
0.01%
-37.5%
Q3 2022$32,505,000
+57.2%
2,036,644
+35.5%
0.01%
+60.0%
Q2 2022$20,680,000
-16.0%
1,502,895
-3.1%
0.01%0.0%
Q1 2022$24,612,000
+69.6%
1,551,774
+133.4%
0.01%
+66.7%
Q4 2021$14,514,000
-49.8%
664,855
-31.3%
0.00%
-50.0%
Q3 2021$28,922,000
-12.0%
967,597
+30.4%
0.01%
-14.3%
Q2 2021$32,877,000
-33.4%
742,305
-33.3%
0.01%
-41.7%
Q1 2021$49,376,000
-4.6%
1,112,835
+17.9%
0.01%
-7.7%
Q4 2020$51,767,000
+100.8%
943,960
-16.3%
0.01%
+85.7%
Q3 2020$25,777,000
+85.5%
1,127,600
+69.8%
0.01%
+75.0%
Q2 2020$13,897,000
+28.3%
663,981
-14.5%
0.00%0.0%
Q1 2020$10,832,000
-31.0%
776,517
+12.7%
0.00%0.0%
Q4 2019$15,688,000
+107.7%
689,246
+6.3%
0.00%
+100.0%
Q3 2019$7,555,000
-15.5%
648,472
+8.8%
0.00%
-33.3%
Q2 2019$8,938,000
-23.9%
595,891
-11.1%
0.00%
-25.0%
Q1 2019$11,751,000
+8.2%
669,995
-8.6%
0.00%
+33.3%
Q4 2018$10,865,000
-17.9%
733,136
+36.5%
0.00%0.0%
Q3 2018$13,228,000
+424.3%
537,277
+299.3%
0.00%
+200.0%
Q1 2018$2,523,000134,5600.00%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
M28 Capital Management LP 665,880$10,627,00011.09%
RTW INVESTMENTS, LP 15,802,802$252,213,0005.82%
Ally Bridge Group (NY) LLC 479,506$7,653,0005.05%
TANG CAPITAL MANAGEMENT LLC 1,265,900$20,204,0002.48%
TIGER MANAGEMENT L.L.C. 279,700$4,464,0001.95%
Prosight Management, LP 200,000$3,192,0001.71%
COWEN AND COMPANY, LLC 999,588$15,953,0001.53%
Boxer Capital, LLC 1,466,051$23,398,0001.32%
Affinity Asset Advisors, LLC 267,794$4,274,0001.19%
HARBOR CAPITAL ADVISORS, INC. 66,410$1,060,0000.97%
View complete list of ROCKET PHARMACEUTICALS INC shareholders